✦ LIBER ✦
Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas
✍ Scribed by Heidi Nyman; Mats Jerkeman; Marja-Liisa Karjalainen-Lindsberg; Alison H. Banham; Gunilla Enblad; Sirpa Leppä
- Book ID
- 114794549
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 315 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0902-4441
No coin nor oath required. For personal study only.